This medication is a used for managing blood sugar levels in adults with type 2 diabetes and well known for chronic weight management in adults who are overweight or obese
A: Most people notice improvements within 1-2 weeks less pain, better digestion, or reduced swelling
Being the first dual GLP-1/GIP receptor agonist to be approved in clinical practice, tirzepatide has better efficacy than the conventional GLP-1 monotherapy
While varenicline neither affect feeding nor body weight, bupropion reduces the food intake in both sexes
Phase 2 trials investigated once-weekly subcutaneous doses of 1 mg to 12 mg with gradual escalation, but no regulatory authority has yet approved the medicine
Zhang Y, Yang C, Xia JJ, Deng L, Wang F, Liu JF (2022) Overproducing nervonic acid by synergism of fatty acid elongases in engineered Saccharomyces cerevisiae